Citation 129933

CRITCHFIELD,JW: WELSH,CJ: PHANG,JM: YEH,GC:. (1994). MODULATION OF ADRIAMYCIN ACCUMULATION AND EFFLUX BY FLAVONOIDS IN HCT-15 COLON CELLS. ACTIVATION OF P-GLYCOPROTEIN AS A PUTATIVE MECHANISM.. 48(7)

Citation Details

TitleMODULATION OF ADRIAMYCIN ACCUMULATION AND EFFLUX BY FLAVONOIDS IN HCT-15 COLON CELLS. ACTIVATION OF P-GLYCOPROTEIN AS A PUTATIVE MECHANISM.
AuthorsCRITCHFIELD,JW: WELSH,CJ: PHANG,JM: YEH,GC:
Year1994
Volume48
Issue7

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
MULTIDRUG RESISTANCE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUINIDINE
ACTIVE
2
MULTIDRUG RESISTANCE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
VINCALEUKOBLASTINE
ACTIVE
3
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FLAVONE
INACTIVE
4
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CHRYSIN
INACTIVE
5
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
APIGENIN
ACTIVE
6
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHOIFOLIN
ACTIVE
7
MULTIDRUG RESISTANCE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DIOSMIN
ACTIVE
8
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
GALANGIN
ACTIVE
9
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FISETIN
ACTIVE
10
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MORIN
ACTIVE
11
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETIN
ACTIVE
12
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RUTIN
ACTIVE
13
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL
ACTIVE
14
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MYRICETIN
ACTIVE
15
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
TAXIFOLIN
WEAK ACTIVITY
16
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NARINGENIN
ACTIVE
17
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NARINGIN
ACTIVE
18
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
HESPERETIN
ACTIVE
19
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
HESPERIDIN
ACTIVE
20
MULTIDRUG RESISTANCE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CHALCONE
WEAK ACTIVITY
21
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHLORETIN
ACTIVE
22
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHLORIDZIN
WEAK ACTIVITY
23
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
GENISTEIN
ACTIVE
24
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BIOCHANIN A
ACTIVE
25
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CATECHIN,(+):
WEAK ACTIVITY
26
MULTIDRUG RESISTANCE ENHANCEMENT
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CATECHIN,EPI: (-):
WEAK ACTIVITY
Show SPARQL Queries (1)